Elevated kynurenine-to-tryptophan ratios (Kyn/Trp) in plasma or tumor tissues correlate with poor prognosis and reduced benefit from PD-1/PD-L1 blockade in melanoma, lung cancer, and hepatocellular carcinoma. The gene discussed is CD274; the disease is hepatocellular carcinoma.